Board Stats

Moleculin Biotech, Inc.

MBRX / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
64	Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming M	GN	jerrykrause		0	5/11/2023 3:53:42 PM

63	Moleculin Announces Final Topline Data from Successful European Phase 1 Trial Evaluat	GN	jerrykrause		0	2/14/2023 12:15:25 PM

62	Klemp bought some stock today at $1.1496 avg.	GN	delt1970		0	11/23/2022 6:48:23 PM

61	What is eating the share price...	GN	alanib		0	10/4/2022 7:54:19 AM

60	Moleculin obtains FDA clearance for Phase I glioma treatment trial	GN	jerrykrause		0	4/23/2022 11:15:28 AM

59	Moleculin Announces Updated Preliminary Safety Data for Annamycin in Its Three Phase 1 Clinical Trials for Acute Myeloid Leukemia and Metastases of Soft Tissue Sarcoma	GN	jerrykrause		0	1/20/2022 1:27:17 PM

58	Moleculin Reports Second Quarter 2021 Financial Results and Provides Programs Update	GN	jerrykrause		0	8/14/2021 11:28:35 AM

57	New Investor Presentation dated March 8, 2021	GN	delt1970		0	3/8/2021 4:33:52 PM

56	New Investor Presentation dated Sept. 1, 2020	GN	delt1970		0	9/1/2020 5:54:07 PM

55	Webinar update June 25 at Life Sciences Forum. Replay available	GN	delt1970		0	6/26/2020 10:51:29 AM

Go to Msg #

BOARDS Sign In for Filters